SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-041687
Filing Date
2017-08-09
Accepted
2017-08-09 16:16:25
Documents
39
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v472241_10q.htm 10-Q 261119
2 EXHIBIT 31.1 v472241_ex31-1.htm EX-31.1 9744
3 EXHIBIT 31.2 v472241_ex31-2.htm EX-31.2 9453
4 EXHIBIT 32.1 v472241_ex32-1.htm EX-32.1 3491
  Complete submission text file 0001144204-17-041687.txt   2516306

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnmx-20170630.xml EX-101.INS 635164
6 XBRL TAXONOMY EXTENSION SCHEMA gnmx-20170630.xsd EX-101.SCH 33981
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnmx-20170630_cal.xml EX-101.CAL 18285
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnmx-20170630_def.xml EX-101.DEF 161919
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnmx-20170630_lab.xml EX-101.LAB 191116
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnmx-20170630_pre.xml EX-101.PRE 175185
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35112 | Film No.: 171018144
SIC: 2836 Biological Products, (No Diagnostic Substances)